Clinical Trial Update: A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 global, open-label randomized trial evaluating RRx-001 with a platinum doublet in small cell lung cancer; the study is currently active and not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• RRx-001

Snippet

Sponsor: EpicentRx, Inc. | Conditions: Carcinoma, Small Cell Lung | Phase 3 | Status: ACTIVE_NOT_RECRUITING